Page last updated: 2024-09-04

olmesartan and Abdominal Pain

olmesartan has been researched along with Abdominal Pain in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Dutra, B; Everett, J; Siddiqui, S1
Arguelles-Grande, C; Bhagat, G; Braunstein, ED; Green, PH; Lagana, SM; Lebwohl, B1
Herman, ML; Kelly, DG; Ludvigsson, JF; Mangan, TF; Murray, JA; Rubio-Tapia, A; Wu, TT1

Other Studies

3 other study(ies) available for olmesartan and Abdominal Pain

ArticleYear
A Clinical Approach to Chronic Diarrhea.
    Gastroenterology, 2022, Volume: 162, Issue:3

    Topics: Abdominal Pain; Aged; Antihypertensive Agents; Chronic Disease; Colonoscopy; Diagnosis, Differential; Diarrhea; Fecal Incontinence; Female; Humans; Imidazoles; Tetrazoles

2022
Sprue-like histology in patients with abdominal pain taking olmesartan compared with other angiotensin receptor blockers.
    Journal of clinical pathology, 2015, Volume: 68, Issue:1

    Topics: Abdominal Pain; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Celiac Disease; Cohort Studies; Female; Humans; Imidazoles; Male; Middle Aged; Retrospective Studies; Tetrazoles

2015
Severe spruelike enteropathy associated with olmesartan.
    Mayo Clinic proceedings, 2012, Volume: 87, Issue:8

    Topics: Abdominal Pain; Aged; Aged, 80 and over; Anemia; Angiotensin II Type 1 Receptor Blockers; Atrophy; Biopsy; Colitis, Microscopic; Collagen; Diarrhea; Fatigue; Female; Gastritis; Hospitalization; Humans; Hypoalbuminemia; Imidazoles; Inflammation; Intestinal Mucosa; Intestines; Lymphocytes; Male; Middle Aged; Nausea; Severity of Illness Index; Stomach; Tetrazoles; Vomiting; Water-Electrolyte Imbalance; Weight Loss; Zinc

2012